p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human Chromosome 19q13.3

  1. Rebecca M. Wolf1,4,
  2. Nicole Draghi1,5,
  3. Xiquan Liang1,
  4. Chengkai Dai1,2,3,4,
  5. Lene Uhrbom3,6,
  6. Charlotta Eklöf6,
  7. Bengt Westermark6,
  8. Eric C. Holland1,2,3,4, and
  9. Marilyn D. Resh1,4,5,7
  1. Departments of 1Cell Biology, 2Surgery, and 3Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA; 4Graduate Program in Cell Biology and Genetics and 5Biochemistry, Weill Graduate School of Medical Sciences of Cornell University, New York, New York 10021, USA; 6Department of Genetics and Pathology, Rudbeck Laboratory, SE-75185, Uppsala, Sweden

Abstract

p190RhoGAP and Rho are key regulators of oligodendrocyte differentiation. The gene encoding p190RhoGAP is located at 19q13.3 of the human chromosome, a locus that is deleted in 50%–80% of oligodendrogliomas. Here we provide evidence that p190RhoGAP may suppress gliomagenesis by inducing a differentiated glial phenotype. Using a cell culture model of autocrine loop PDGF stimulation, we show that reduced Rho activity via p190RhoGAP overexpression or Rho kinase inhibition induced cellular process extension, a block in proliferation, and reduced expression of the neural precursor marker nestin. In vivo infection of mice with retrovirus expressing PDGF and the p190 GAP domain caused a decreased incidence of oligodendrogliomas compared with that observed with PDGF alone. Independent experiments revealed that the retroviral vector insertion site in 3 of 50 PDGF-induced gliomas was within the p190RhoGAP gene. This evidence strongly suggests that p190 regulates critical components of PDGF oncogenesis and can act as a tumor suppressor in PDGF-induced gliomas by down-regulating Rho activity.

Keywords

Footnotes

  • 7 Corresponding author.

  • E-MAIL m-resh{at}ski.mskcc.org; FAX (212) 717-3317.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1040003.

    • Received September 9, 2002.
    • Accepted January 9, 2003.
| Table of Contents

Life Science Alliance